Coverage
-
September 17, 2025
A New York bankruptcy judge on Wednesday approved the $22 million credit bid sale of bankrupt biopharmaceutical company Seelos Therapeutics after hearing the buyer had agreed to add another $100,000 in cash to its offer.
3 other articles on this case.
View all »